No fewer than 19 cases were filed in West Virginia alleging that when women prescribed Zoloft undertook a Zoloft pregnancy, they were not aware of the potential hazards and heartbreak associated with Zoloft, and the impact its use would have on their unborn children.
Named in the various lawsuits were Roeirg, a division of Pfizer Inc., and Greenstone LLC.
According to the West Virginia Record (8/9/12), the case was filed in Wayne Circuit Court and assigned to Circuit Judge James H. Young. The plaintiffs claim their Zoloft defects include, but are not limited to: atrial septal defect; multiple holes in the heart and/or began to suffer from persistent pulmonary hypertension of the newborn; neural tube defects; craniofacial defects; and other adverse malformations.
Other defects linked to Zoloft can include Zoloft cleft palate and Zoloft craniosynostosis.
As has been the case with other lawsuits, the plaintiffs claim they had no knowledge of the potential for Zoloft effects on the fetus when they commenced treatment with Zoloft at a dosage recommended by the defend(s) and on the advice, and authorization of their respective prescribing physicians.
READ MORE ZOLOFT BIRTH DEFECTS LEGAL NEWS
Zoloft, according to the lawsuit, is dangerous and defective with the potential to cause birth defects. The lawsuit also accuses the defend tat(s) of improper labeling, given their allegation that packaging and labeling lacks sufficient warnings pertaining to potential defects. Those defects can include Zoloft neural tube, Zoloft anal atresia, Zoloft omphalocele.
The plaintiffs are seeking compensatory and punitive damages with pre, and post-judgment interest.
The Zoloft birth defects lawsuit claims injuries suffered by the minor plaintiffs were directly caused by a Zoloft pregnancy.